| The Safety and Efficacy of Clindamycin and Primaquine in the Treatment of Mild - Moderate Pneumocystis Carinii Pneumonia in Patients With AIDS (NCT00000717) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Pharmacokinetics of Zidovudine and Oxazepam Alone and in Combination in the HIV-Infected Patient (NCT00000661) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin (HVIG) Plus Zidovudine in HIV-Infected Infants (NCT00000961) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| TMC114-C226: An Early Access Program to Evaluate the Long-term Safety and Tolerability of TMC114 Combined With a Low Dose of Ritonavir (TMC114/r) With Other Antiretrovirals, for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens. (NCT00245739) | Tibotec Pharmaceuticals, Ireland | |
| Phase I/II Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients (NCT00002098) | AJI Pharma USA | |
| Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients (NCT00002052) | University of Southern California | |
| A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC (NCT00000735) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A "Pre-Enrollment" Protocol for HIV-Infected Adolescents (NCT00000780) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of Infection (NCT00001036) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood (NCT00000916) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral/Oral Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia in AIDS (NCT00000715) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors (NCT00002420) | Bristol-Myers Squibb | |
| A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate (Neutrexin) With Leucovorin Protection for European Adult Patients (>= 13 Years Old) With Pneumocystis Carinii Pneumonia (NCT00002103) | U.S. Bioscience | |
| Study of Anti-HIV Therapy Intensification (NCT00034086) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAU (NCT00000654) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3 (NCT00000754) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure (NCT00000691) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Double-Blind, Randomized, Dose Ranging Study of Alferon LDO (Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)) in HIV+ Subjects (NCT00002018) | Interferon Sciences | |
| A Study of Nevirapine Used Alone or in Combination With AZT in HIV-1-Infected Children (NCT00001111) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Therakos UVAR Photopheresis System in the Treatment of AIDS-Related Complex (NCT00002011) | Therakos | |
| A Study to See if Certain Antioxidants and Vitamins Will Keep Lactate Levels Down in Patients Taking Anti-HIV Drugs (NCT00037063) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral Pentamidine (NCT00001990) | Glaxo Wellcome | |
| A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected Patients (NCT00002190) | Hoffmann-La Roche | |
| Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS (NCT00001014) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy (NCT00102206) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Use of Muscle Spectroscopy to Evaluate Mitochondrial Dysfunction in HIV-Infected Patients (NCT00036478) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effectiveness of CD4-IgG2 in HIV-Positive Children (NCT00000876) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Ritonavir and Agenerase Treatment for Patients Who Have Failed Previous Anti-HIV Treatment (NCT00006591) | Gathe, Joseph, M.D. | |
| Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals (NCT00001080) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase III Multicenter, Open-Label, Randomized Trial of Induction Versus Induction Plus Maintenance Foscarnet ( Foscavir ) Therapy for Gastrointestinal CMV Disease (NCT00002145) | Astra USA | |
| An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients (NCT00002039) | Astra USA | |
| Safety and Effectiveness of an Anti-HIV Drug Combination With and Without Hydroxyurea in Patients With Early HIV Infection (NCT00006339) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With Advanced HIV Disease (NCT00000814) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected Patients (NCT00002327) | Gilead Sciences | |
| A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns (NCT00000642) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Evaluation of the Epidermal Langerhans Cell Population in AIDS / ARC Patients by the Topical Application of a Potent Contact Allergen (1-Chloro-2,4-Dinitro-Chlorobenzene) (DNCB) (NCT00002031) | University of California, San Francisco | |
| A Phase I Study of Subcutaneously Administered Proleukin (Aldesleukin) in HIV-Infected Patients (NCT00002107) | Chiron Corporation | |
| Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs (NCT00013871) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase I Study of Safety, Tolerability, and Pharmacokinetics of Viracept in HIV-1 Infected Children and Exposed Infants (NCT00002164) | Agouron Pharmaceuticals | |
| A Study of Azithromycin in the Prevention of Mycobacterium Avium Complex Disease (MAC) in HIV-Infected Patients (NCT00002309) | Pfizer | |
| Double Blind Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients (NCT00002049) | Immunobiology Research Institute | |
| Effectiveness of Anti-HIV Drugs in Patients Who Have Not Received Previous Anti-HIV Drugs During Different Stages of HIV Infection (NCT00006443) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir (NCT00000970) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women (NCT00000758) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Zidovudine and T Lymphocyte Transfer in the Treatment of HIV Type III in Patients With AIDS (NCT00002285) | Glaxo Wellcome | |
| A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Children Who Cannot Take Trimethoprim-Sulfamethoxazole (NCT00001027) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Acceptability of the Anti-Microbe Vaginal Gel, PMPA Gel (NCT00028132) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Dideoxycytidine ( Ro 24-2027 ) A Randomized, Open-Label, Comparative Study of Dideoxycytidine ( ddC ) Versus Zidovudine ( AZT ) in Patients With AIDS or Advanced ARC Who Have Received Long-Term AZT Therapy. (NCT00000678) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Ribavirin in the Treatment of Patients With AIDS and AIDS-Related Problems (NCT00001015) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access (NCT00002135) | Hoffmann-La Roche | |
| The Safety and Effectiveness of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs (NCT00002425) | Hoffmann-La Roche | |
| Study of a New Anti-HIV Drug, T-20, in HIV-Infected Children (NCT00001118) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma (NCT00002259) | Lederle Laboratories | |
| Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV (NCT00017992) | Triangle Pharmaceuticals | |
| Pharmacokinetics of Nystatin LF I.V. in Patients With Acquired Immune Deficiency Syndrome-Related Complex (ARC) (NCT00001998) | Argus Pharmaceuticals | |
| A Double-Blind Group Comparative Study To Evaluate the Long-Term Safety and Effectiveness of Two Different Doses of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients With Multiple Episodes of PCP (NCT00002055) | Fisons | |
| A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDS (NCT00002294) | Pfizer | |
| A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated Schedules (NCT00000957) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs (NCT00002440) | Glaxo Wellcome | |
| Study of Women Who Have AIDS (NCT00001050) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide Immunogen, Given by IM Injection, in Combination With the UBI Microparticulate Monovalent HIV-1 MN Branched Peptide Given Orally, in HIV-1 Uninfected Volunteers. (NCT00000846) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Compare the Safety and Immunogenicity of Recombinant Envelope Protein rgp120/HIV-1SF2 (BIOCINE) Combined With Seven Adjuvants in Healthy HIV-1 Uninfected Individuals (NCT00001042) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Initial Phase II Efficacy and Safety Study of SC-48334 Administered in Combination With Low-Dose Zidovudine (AZT) to Symptomatic HIV-1 Infected Patients With = or > 200 to = or < 500 CD4+ Cells/mm3 (NCT00001993) | G D Searle | |
| Handheld Computers to Improve Adherence to Anti-HIV Drug Regimens (NCT00053443) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I/II Study of Delayed-Type Hypersensitivity (DTH) Reactions to Intradermal HIV Envelope Antigen (NCT00000782) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen (NCT00002238) | Bayer | |
| A Study of 1592U89 in HIV-Infected Patients (NCT00002388) | Glaxo Wellcome | |
| The Effects of Valproic Acid on Zidovudine Glucuronidation and Pharmacokinetics in HIV-Infected Patients. (NCT00000629) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related Complex (NCT00000675) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Valacyclovir Hydrochloride in the Prevention of Life-Threatening Cytomegalovirus Disease in HIV-Infected Patients (NCT00001038) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis (NCT00002159) | Janssen, LP | |
| A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 (NCT00000972) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS (NCT00002299) | Hoffmann-La Roche | |
| Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection (NCT00000955) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV Drugs (NCT00050908) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Problems Associated With the Use of Anti-HIV Drugs in HIV-Infected Pregnant Women (NCT00017797) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effectiveness of Zintevir (AR177) Given to HIV-Infected Patients (NCT00002403) | Aronex Pharmaceuticals | |
| A Multicenter, Double-Blind, Controlled Study to Evaluate Ampligen (NCT00002269) | HEM Research | |
| The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 Weeks (NCT00001063) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Effectiveness of Giving an HIV Vaccine (Remune) to HIV-Positive Patients Receiving an Anti-HIV Drug Combination (NCT00005758) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Intranasal Peptide T in the Treatment of Painful Peripheral Neuropathy of AIDS (NCT00002083) | Advanced Peptides | |
| Nitazoxanide for the Treatment of Chronic Diarrhea in HIV Infected Children (NCT00055107) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis (NCT00002068) | Pfizer | |
| Botswana Study of UC-781 Vaginal Microbicide (NCT00385554) | Centers for Disease Control and Prevention | |
| A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP300 and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers (NCT00001072) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients (NCT00002201) | Abbott | |
| Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS (NCT00001047) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Immunomodulation of HIV-1 Infected Individuals With PEG-Interleukin-2 (NCT00002017) | Rockefeller University | |
| A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients (NCT00002140) | Pfizer | |
| An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts (NCT00000709) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine (BI-RG-587) in HIV-Infected Patients With CD4 Cell Count >= 500/mm3 (NCT00000747) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive Individuals (NCT00001026) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine (NCT00002035) | Bristol-Myers Squibb | |
| A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma (NCT00002319) | Sequus Pharmaceuticals | |
| A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection (NCT00002117) | Hoffmann-La Roche | |
| A Study of Decreased Mental Function Associated With HIV (NCT00027040) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3 (NCT00000859) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy (NCT00000803) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of 141W94 in Combination With Other Anti-HIV Drugs (NCT00002372) | Glaxo Wellcome | |
| Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat (NCT00009555) | National Institute of Allergy and Infectious Diseases (NIAID) | |